Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MOCON is an analytical instrumentation and testing-services company focused on gas measurement, permeation analysis, package integrity testing, and specialty gas detection. Originally founded as MOCON, Inc. and later acquired by AMETEK in 2017, it now operates as AMETEK MOCON. The company serves healthcare, pharmaceutical, medical device, food packaging, industrial, environmental, and safety markets with instruments such as oxygen, water vapor, and carbon dioxide transmission-rate analyzers, headspace analyzers, leak and seal integrity systems, and gas chromatographs. In healthcare, MOCON supports pharmaceutical and medical device packaging validation, sterility assurance, and ethylene oxide monitoring, and also offers ISO 17025-accredited laboratory testing services. It is not a drug developer or therapeutic biotech company; rather, it is a commercial provider of enabling test equipment and services used across life science and packaging workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MOCON.